Associated Papers
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Singh S et al.
Nature, 2025
40836083 (PubMed )
Supplement: 41586_2025_9433_MOESM4_ESM.zip › 2024-07-15654B-s4 › Table_S5_052925.xlsx › Tab_8-zscore_CDK2_C_T
Association of protein function-altering variants with cardiometabolic traits: the strong heart study.
Shan Y et al.
Scientific Reports, 2022
35665752 (PubMed )
Supplement: 41598_2022_12866_MOESM2_ESM.xlsx › TableS3
Select a paper to view details